Publication
Palbociclib as single agent or in combination with the endocrine therapy received before disease progression for estrogen receptor-positive, HER2-negative metastatic breast cancer: TREnd trial
L. Malorni, G. Curigliano, A.M. Minisini, S. Cinieri, C.A. Tondini, K. D’Hollander, G. Arpino, A. Bernardo, A. Martignetti, C. Criscitiello, F. Puglisi, M. Pestrin, G. Sanna, E. Moretti, E. Risi, C. Biagioni, A. McCartney, L. Boni, M. Buyse, I. Migliaccio, L. Biganzoli, A. Di Leo
Annals of Oncology, August 2018, Elsevier
DOI: 10.1093/annonc/mdy214